Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors



Status:Completed
Conditions:Breast Cancer, Ovarian Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cervical Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Women's Studies
Therapuetic Areas:Oncology, Reproductive
Healthy:No
Age Range:18 - Any
Updated:2/23/2018
Start Date:August 1, 2015
End Date:October 31, 2016

Use our guide to learn which trials are right for you!

A Pilot Study of the Clinical Implementation of the Carevive Survivor Care Planning System

This pilot clinical trial studies how well the Carevive Survivor Care Planning System works
in improving quality of life in breast cancer survivors. A personalized survivor care plan
includes a summary of a patient's cancer treatment and a customized survivor care plan and
may provide beneficial information and resources.

PRIMARY OBJECTIES:

I. To evaluate the feasibility of using the Carevive Survivor Care Planning System (SCPS)
during the follow-up visit for breast oncology survivors treated in a university cancer
center or a community medical center.

II. To evaluate survivors' perceptions of the usability of the Carevive technology.

III. To evaluate their perceptions of the acceptability (perception of benefit) of the
treatment summary and survivor care plan.

SECONDARY OBJECTIVES:

I. Examine the psychometrics of surveys developed for this research. II. Compare
participants' perceptions of the care received under the Carevive system with clinician
documentation.

III. Compare clinician documentation of care received by this sample with documentation of
care provided for historical controls at each site.

Inclusion Criteria:

- Prospective study: completed primary treatment for breast malignancies; receive
survivorship care at Thomas Jefferson University (TJU) or Reading Health System (RHS)

- Prospective study: individuals will have pathologically confirmed breast cancer
(stages I-III)

- Prospective study: Able to understand and read English

- Prospective study: Physically capable of using a tablet computer (no severe visual,
hearing, or hand motor deficits)

- Retrospective chart review: Individuals will have pathologically confirmed breast
cancer or gynecological (GYN) malignancies including uterine, ovarian, or cervical
cancers, stages I-III; treated in the previous two years (2013-2014)

Exclusion Criteria:

- Women who are pregnant

- Vulnerable populations: cognitively impaired; prisoners; terminally ill; elderly and
infirm; drug addicts
We found this trial at
2
sites
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Reading, Pennsylvania 19601
?
mi
from
Reading, PA
Click here to add this to my saved trials